[Presenile and senile vulvovaginitis. Topical hormonal treatment with estriol].
A population of 39 women (average age 64.5 years) suffering from presenile or senile vulvovaginitis was subjected to topical treatment with oestriol-based vaginal cream (daily applications of 0.50 mg of oestriol corresponding to 4 g of cream for 14 days and three times a week in the three following weeks). The results of treatment were assessed on the basis of the clear-cut improvement in symptomatology and the noteworthy increase in the index and volume of maturation of the vaginal epithelium. The effectiveness of topical treatment of postmenopausal vulvovaginitis with oestriol in the absence of unwanted side-effects is confirmed.
Sonni
R
R
Clinica Ginecologica ed Ostetrica, Università degli Studi G. D'Annunzio, Chieti.
Bondi
G
G
Travaglini
S
S
D000367:Age Factors; D000368:Aged; D000375:Aging; D004964:Estriol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D014848:Vulvovaginitis / Q000188:drug therapy* / Q000503:physiopathology
D004964:Estriol
Vulvovaginiti presenili e senili. Trattamento topico ormonale con estriolo.